Objectives: Allogeneic hematopoietic stem cell transplantation (HSCT) is an increasingly common treatment for malignant and non-malignant hematologic diseases. The major limitation to the realization of this type of transplant is access to an HLA-identical donor within the family. Only 30% of patients referred for transplantation will have an appropriate RD; using HLA-identical URD is an alternative for these patients. The aim of this study is to describe the first experience in Colombia with this type of transplant. Materials and Methods: Observational case series. Results: From July 1, 2011, have been 89 searches have been started. The most frequent diagnosis acute leukemia (47 ALL, 25 AML). Since there isn't a national donors registry, searches were performed through NMDP. 26 matched-URD (10/10 or 9/10) were found (29.81%) and 14 transplants have been performed. 8 patients with an URD died before transplantation, 2 lost indication and 2 transplants are waiting.
2 patients died due to sepsis before engraftment could be evaluated. From the 87 evaluable patients, 5 had primary graft failure and 4 secondary graft failure. 7/9 patients with graft failure had a second transplant (5 from the same donor and 2 from an haploidentical relative). 6 of those 7 transplants engrafted and are alive. Non-myeloablative conditioning containing Fludarabine, resulted in less hospital stay compared to Cy-ATG and Cy alone (22.9, 32, 33 days respectively), less fever (1.7, 6.7, 7 days), less parenteral nutrition (0.1, 9, 4 days) and less red cells (2.4, 3.8, 3.8) and platelet (4.5, 7.5, 9.75) transfusions. Rates of GII-IV aGVHD were also less frequent for Cy-Flu-ATG group 8% compared to Gy-ATG (18%) or Cy (25% 
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The Addition of Extracorporeal Photophoresis (ECP) to Tacrolimus and Methotrexate to Prevent Acute and Chronic Graft-Versus Host Disease (aGvHD, cGvHD) in
